Innomedica Holding Ag Is A Swiss Biopharmaceutical Company Based In Bernspecializing In Nanotechnology Based Drug Delivery Systemswith A Team Of Around 50 Employeesthe Company Focuses On Enhancing Therapeutic Efficacy And Minimizing Side Effects Through Its Proprietary Liposomal Formulations Innomedica Develops Innovative Nanocarriers That Optimize Drug Biodistribution By Extending Circulation Time And Enabling Targeted Release At Specific Tissuestheir Patent Protected Nanotransport System Combines Liposomal Technology With A Biologicalautopilotmechanismimproving Drug Delivery Precision For Conditions Such As Cancer And Neurodegenerative Diseasesthe Company S Product Pipeline Includes Talidoxa Liposomal Formulation Of Doxorubicin For Targeted Cancer Therapyand Tacurecaimed At Treating Neurodegenerative Disorders Like Parkinsonae S Disease And Alsinnomedica Also Engages In National And International Research Partnerships To Further Its Mission Of Addressing Unmet Medical Needs In High Demand Therapeutic Areas
No conferences found for this company.
| Company Name | Innomedica Holding Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
